Cabaletta Bio Stock Price on April 9, 2024
| CABA Stock | USD 2.38 0.07 3.03% |
Below is the normalized historical share price chart for Cabaletta Bio extending back to October 25, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cabaletta Bio stands at 2.38, as last reported on the 21st of December, with the highest price reaching 2.51 and the lowest price hitting 2.23 during the day.
If you're considering investing in Cabaletta Stock, it is important to understand the factors that can impact its price. Cabaletta Bio secures Sharpe Ratio (or Efficiency) of -0.0668, which signifies that the company had a -0.0668% return per unit of standard deviation over the last 3 months. Cabaletta Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cabaletta Bio's risk adjusted performance of (0.05), and Mean Deviation of 6.28 to double-check the risk estimate we provide.
At present, Cabaletta Bio's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 266.3 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 28.3 M. . At present, Cabaletta Bio's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 1.91, whereas Price Earnings Ratio is forecasted to decline to (14.42). Cabaletta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of October 2019 | 200 Day MA 8.258 | 50 Day MA 3.5599 | Beta 2.419 |
Cabaletta |
Sharpe Ratio = -0.0668
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CABA |
Estimated Market Risk
| 8.71 actual daily | 77 77% of assets are less volatile |
Expected Return
| -0.58 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cabaletta Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cabaletta Bio by adding Cabaletta Bio to a well-diversified portfolio.
Price Book 0.648 | Book Value 4.939 | Enterprise Value -51.5 M | Enterprise Value Ebitda (3.44) | Shares Float 41.3 M |
Related Headline
Day One Headline on 9th of April 2024
Disposition of 20000 shares by Blackman Samuel C. of Day One... by Blackman Samuel C.
Filed transaction by Day One Biopharmaceuticals Officer Head Of Rd. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Cabaletta Bio Valuation on April 9, 2024
It is possible to determine the worth of Cabaletta Bio on a given historical date. On April 9, 2024 Cabaletta was worth 17.99 at the beginning of the trading date compared to the closed value of 18.82. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cabaletta Bio stock. Still, in general, we apply an absolute valuation method to find Cabaletta Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cabaletta Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cabaletta Bio's related companies.
| Open | High | Low | Close | Volume | |
| 17.00 | 18.33 | 16.85 | 18.04 | 1,051,835 | |
04/09/2024 | 17.99 | 19.04 | 17.69 | 18.82 | 1,116,972 |
| 18.20 | 18.53 | 17.59 | 17.86 | 1,046,985 |
| Backtest Cabaletta Bio | | | Cabaletta Bio History | | | Cabaletta Bio Valuation | Previous | Next |
Cabaletta Bio Trading Date Momentum on April 9, 2024
| On April 10 2024 Cabaletta Bio was traded for 17.86 at the closing time. The top price for the day was 18.53 and the lowest listed price was 17.59 . The trading volume for the day was 1 M. The trading history from April 10, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.10% . The overall trading delta against the current closing price is 26.14% . |
Cabaletta Bio Fundamentals Correlations and Trends
By evaluating Cabaletta Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cabaletta Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cabaletta financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cabaletta Bio Stock history
Cabaletta Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cabaletta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cabaletta Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cabaletta Bio stock prices may prove useful in developing a viable investing in Cabaletta Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 40.9 M | 28.3 M | |
| Net Loss | -47.7 M | -45.3 M |
Cabaletta Bio Quarterly Net Working Capital |
|
Cabaletta Bio Stock Technical Analysis
Cabaletta Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cabaletta Bio Period Price Range
Low | December 21, 2024
| High |
0.00 | 0.00 |
Cabaletta Bio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cabaletta Bio December 21, 2024 Market Strength
Market strength indicators help investors to evaluate how Cabaletta Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cabaletta Bio shares will generate the highest return on investment. By undertsting and applying Cabaletta Bio stock market strength indicators, traders can identify Cabaletta Bio entry and exit signals to maximize returns
Cabaletta Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cabaletta Bio's price direction in advance. Along with the technical and fundamental analysis of Cabaletta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cabaletta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.77) | |||
| Total Risk Alpha | (0.92) | |||
| Treynor Ratio | (0.16) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |